BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maeda S, Wada H, Naito Y, Nagano H, Simmons S, Kagawa Y, Naito A, Kikuta J, Ishii T, Tomimaru Y, Hama N, Kawamoto K, Kobayashi S, Eguchi H, Umeshita K, Ishii H, Doki Y, Mori M, Ishii M. Interferon-α acts on the S/G2/M phases to induce apoptosis in the G1 phase of an IFNAR2-expressing hepatocellular carcinoma cell line. J Biol Chem 2014;289:23786-95. [PMID: 25012666 DOI: 10.1074/jbc.M114.551879] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Yin H, Liao CG, Huang JG, Wang YQ, Li Z, Fan LL, Qian ML, Wan N, Lu N. Interferon-α adjuvant therapy decreases the recurrence of early clear cell renal cell carcinoma and improves the prognosis of Chinese patients. Oncotarget 2017;8:113185-93. [PMID: 29348897 DOI: 10.18632/oncotarget.18567] [Reference Citation Analysis]
2 Chen S, Liang L, Wang Y, Diao J, Zhao C, Chen G, He Y, Luo C, Wu X, Zhang Y. Synergistic immunotherapeutic effects of Lycium barbarum polysaccharide and interferon-α2b on the murine Renca renal cell carcinoma cell line in vitro and in vivo. Mol Med Rep 2015;12:6727-37. [PMID: 26300071 DOI: 10.3892/mmr.2015.4230] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
3 Zhang L, Tai YT, Ho MZG, Qiu L, Anderson KC. Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today's treat-to-target era. Exp Hematol Oncol 2017;6:20. [PMID: 28725493 DOI: 10.1186/s40164-017-0081-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
4 Priosoeryanto BP, Rostantinata R, Harlina E, Nurcholis W, Ridho R, Sutardi LN. In vitro antiproliferation activity of Typhonium flagelliforme leaves ethanol extract and its combination with canine interferons on several tumor-derived cell lines. Vet World 2020;13:931-9. [PMID: 32636590 DOI: 10.14202/vetworld.2020.931-939] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Yin H, Chen N, Guo R, Wang H, Li W, Wang G, Cui J, Jin H, Hu JF. Antitumor potential of a synthetic interferon-alpha/PLGF-2 positive charge peptide hybrid molecule in pancreatic cancer cells. Sci Rep 2015;5:16975. [PMID: 26584517 DOI: 10.1038/srep16975] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
6 Khan A, Dias F, Neekhra S, Singh B, Srivastava R. Designing and Immunomodulating Multiresponsive Nanomaterial for Cancer Theranostics. Front Chem 2020;8:631351. [PMID: 33585406 DOI: 10.3389/fchem.2020.631351] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Xiao Y, Wang Z, Zhao M, Ji W, Xiang C, Li T, Wang R, Yang K, Qian C, Tang X, Xiao H, Zou Y, Liu H. . MBE 2022;19:9481-504. [DOI: 10.3934/mbe.2022441] [Reference Citation Analysis]
8 Wu Y, Zhao W, Liu Y, Tan X, Li X, Zou Q, Xiao Z, Xu H, Wang Y, Yang X. Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response. EMBO J 2018;37:e99017. [PMID: 30158112 DOI: 10.15252/embj.201899017] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 13.3] [Reference Citation Analysis]
9 Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G. Type I interferons in anticancer immunity. Nat Rev Immunol 2015;15:405-14. [PMID: 26027717 DOI: 10.1038/nri3845] [Cited by in Crossref: 509] [Cited by in F6Publishing: 491] [Article Influence: 72.7] [Reference Citation Analysis]
10 Yamashita M, Wada H, Eguchi H, Ogawa H, Yamada D, Noda T, Asaoka T, Kawamoto K, Gotoh K, Umeshita K, Doki Y, Mori M. A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma. Int J Oncol. 2016;49:89-98. [PMID: 27121124 DOI: 10.3892/ijo.2016.3496] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
11 Lau E, Sedy J, Sander C, Shaw MA, Feng Y, Scortegagna M, Claps G, Robinson S, Cheng P, Srivas R, Soonthornvacharin S, Ideker T, Bosenberg M, Gonzalez R, Robinson W, Chanda SK, Ware C, Dummer R, Hoon D, Kirkwood JM, Ronai ZA. Transcriptional repression of IFNβ1 by ATF2 confers melanoma resistance to therapy. Oncogene 2015;34:5739-48. [PMID: 25728676 DOI: 10.1038/onc.2015.22] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
12 Wang F, Lv H, Li Y, Han T, Liu H, Jia K, Liu F, Gao Y, Wang F. Complete cure of a patient with HBV-associated hepatocellular carcinoma with lung metastasis using interferon and survival up to 108 months: A case report and literature review. Oncol Lett 2018;16:2979-88. [PMID: 30127887 DOI: 10.3892/ol.2018.9033] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Catani JPP, Medrano RFV, Hunger A, Del Valle P, Adjemian S, Zanatta DB, Kroemer G, Costanzi-Strauss E, Strauss BE. Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma. Transl Oncol 2016;9:565-74. [PMID: 27916291 DOI: 10.1016/j.tranon.2016.09.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
14 Imig D, Pollak N, Allgöwer F, Rehm M. Sample-based modeling reveals bidirectional interplay between cell cycle progression and extrinsic apoptosis. PLoS Comput Biol 2020;16:e1007812. [PMID: 32497127 DOI: 10.1371/journal.pcbi.1007812] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Marchini A, Daeffler L, Pozdeev VI, Angelova A, Rommelaere J. Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study.Front Immunol. 2019;10:1848. [PMID: 31440242 DOI: 10.3389/fimmu.2019.01848] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 8.7] [Reference Citation Analysis]
16 Wang H, Liu H, Zhao X, Chen X. Heterogeneous nuclear ribonucleoprotein U-actin complex derived from extracellular vesicles facilitates proliferation and migration of human coronary artery endothelial cells by promoting RNA polymerase II transcription. Bioengineered 2022;13:11469-86. [PMID: 35535400 DOI: 10.1080/21655979.2022.2066754] [Reference Citation Analysis]
17 Renn LA, Theisen TC, Navarro MB, Mane VP, Schramm LM, Kirschman KD, Fabozzi G, Hillyer P, Puig M, Verthelyi D, Rabin RL. High-throughput quantitative real-time RT-PCR assay for determining expression profiles of types I and III interferon subtypes. J Vis Exp 2015. [PMID: 25867042 DOI: 10.3791/52650] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
18 Fan L, Xu G, Cao J, Li M, Zhang H, Li F, Qi X, Zhang X, Li Z, Han P, Yang X. Type I Interferon Promotes Antitumor T Cell Response in CRPC by Regulating MDSC. Cancers (Basel) 2021;13:5574. [PMID: 34771735 DOI: 10.3390/cancers13215574] [Reference Citation Analysis]
19 Yu RMC, Selvarajah GT, Tan GC, Cheah Y, Singh A. In Vitro Growth Inhibition, Caspase-Dependent Apoptosis, and S and G2/M Phase Arrest in Breast Cancer Cells Induced by Fluorine-Incorporated Gold I Compound, Ph3PAu[SC(OMe)=NC6H4F-3]. International Journal of Breast Cancer 2022;2022:1-18. [DOI: 10.1155/2022/7168210] [Reference Citation Analysis]
20 Kim Y, Lee D, Lee J, Lee S, Lawler S. Role of tumor-associated neutrophils in regulation of tumor growth in lung cancer development: A mathematical model. PLoS One 2019;14:e0211041. [PMID: 30689655 DOI: 10.1371/journal.pone.0211041] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
21 Murata T, Honda T, Egawa G, Yamamoto Y, Ichijo R, Toyoshima F, Dainichi T, Kabashima K. Transient elevation of cytoplasmic calcium ion concentration at a single cell level precedes morphological changes of epidermal keratinocytes during cornification. Sci Rep 2018;8:6610. [PMID: 29700333 DOI: 10.1038/s41598-018-24899-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]